Guardant Well being (NASDAQ:GH) Inventory Worth Down 3%
Guardant Well being, Inc. (NASDAQ:GH – Get Ranking) fell 3% throughout mid-day buying and selling on Friday . The corporate traded as little as $26.00 and final traded at $26.24. 1,150 shares modified fingers throughout mid-day buying and selling, a decline of 100% from the common session quantity of two,133,132 shares. The inventory beforehand closed at $27.05.
Wall Avenue Analysts Forecast Development
Various brokerages have just lately commented on GH. BTIG Analysis lower their value goal on shares of Guardant Well being from $80.00 to $60.00 in a analysis report on Friday, December sixteenth. JPMorgan Chase & Co. decreased their value goal on Guardant Well being from $100.00 to $85.00 and set an “obese” ranking for the corporate in a report on Friday, November 18th. Stephens dropped their goal value on Guardant Well being from $99.00 to $90.00 and set an “obese” ranking on the inventory in a report on Monday, November seventh. Craig Hallum initiated protection on Guardant Well being in a analysis be aware on Wednesday, October nineteenth. They issued a “purchase” ranking and a $88.00 goal value for the corporate. Lastly, Financial institution of America elevated their value goal on Guardant Well being from $65.00 to $70.00 in a report on Friday, December sixteenth. One fairness analysis analyst has rated the inventory with a maintain ranking and fourteen have assigned a purchase ranking to the corporate. In line with information from MarketBeat.com, the inventory presently has a mean ranking of “Average Purchase” and a consensus value goal of $93.59.
Guardant Well being Buying and selling Up 0.6 %
The corporate has a debt-to-equity ratio of 6.82, a fast ratio of 6.10 and a present ratio of 6.46. The inventory has a market capitalization of $2.79 billion, a price-to-earnings ratio of -4.59 and a beta of 0.64. The enterprise has a fifty day easy shifting common of $43.75 and a 200 day easy shifting common of $47.77.
Guardant Well being (NASDAQ:GH – Get Ranking) final launched its quarterly earnings outcomes on Thursday, November third. The corporate reported ($1.58) EPS for the quarter, lacking the consensus estimate of ($1.27) by ($0.31). Guardant Well being has a destructive internet margin of 140.58% and a destructive return on fairness of 145.58%. The enterprise had income of $117.40 million through the quarter, in comparison with analyst estimates of $118.18 million. As a bunch, analysis analysts count on that Guardant Well being, Inc. will submit -6.39 EPS for the present 12 months.
Insider Exercise
In different Guardant Well being information, insider Kumud Kalia bought 3,125 shares of Guardant Well being inventory in a transaction on Tuesday, November fifteenth. The inventory was bought at a mean value of $51.87, for a complete worth of $162,093.75. Following the completion of the transaction, the insider now immediately owns 20,135 shares of the corporate’s inventory, valued at roughly $1,044,402.45. The sale was disclosed in a authorized submitting with the Securities & Alternate Fee, which is accessible by way of this hyperlink. 5.90% of the inventory is owned by firm insiders.
Hedge Funds Weigh In On Guardant Well being
Hedge funds have just lately purchased and bought shares of the corporate. Xponance Inc. lifted its holdings in shares of Guardant Well being by 2.4% through the third quarter. Xponance Inc. now owns 11,639 shares of the corporate’s inventory price $627,000 after buying a further 269 shares through the interval. Captrust Monetary Advisors raised its place in Guardant Well being by 33.2% through the second quarter. Captrust Monetary Advisors now owns 1,087 shares of the corporate’s inventory valued at $44,000 after buying a further 271 shares within the final quarter. Commonwealth Fairness Providers LLC lifted its stake in Guardant Well being by 4.9% through the second quarter. Commonwealth Fairness Providers LLC now owns 6,120 shares of the corporate’s inventory price $246,000 after buying a further 286 shares over the last quarter. Manchester Capital Administration LLC boosted its holdings in shares of Guardant Well being by 43.0% within the third quarter. Manchester Capital Administration LLC now owns 965 shares of the corporate’s inventory valued at $52,000 after buying a further 290 shares within the final quarter. Lastly, Baird Monetary Group Inc. elevated its stake in shares of Guardant Well being by 2.1% within the third quarter. Baird Monetary Group Inc. now owns 14,580 shares of the corporate’s inventory valued at $785,000 after buying a further 296 shares over the last quarter. 90.43% of the inventory is owned by institutional traders.
Guardant Well being Firm Profile
(Get Ranking)
Guardant Well being, Inc, a precision oncology firm, offers blood checks, information units, and analytics in america and internationally. The corporate affords Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based checks for superior stage most cancers; and GuardantINFORM, an in-silico analysis platform that includes a clinical-genomic liquid biopsy dataset of superior most cancers sufferers.
See Additionally
Obtain Information & Scores for Guardant Well being Day by day – Enter your e-mail deal with under to obtain a concise every day abstract of the most recent information and analysts’ scores for Guardant Well being and associated corporations with MarketBeat.com’s FREE every day e-mail e-newsletter.